Skip to main content

IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treamtent

Low-Res Banner

Researchers from IBM and the Institute for Bioengineering and Nanotechnology published a nanomedicine breakthrough in Nature Chemistry, demonstrating the first biodegradable antimicrobial polymer nanoparticles to combat drug-resistant bacteria and infectious diseases like Methicillin-resistant Staphylococcus aureus, known as MRSA. Unlike conventional antibiotics, these nanostructures target infected cells without destroying healthy red blood cells.

News releases
Date Title
04 Apr 2011 IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment

Images

  • low

    IBM Research nanomedicine breakthrough

    Date added: 02 Apr 2011

    The antimicrobial agents developed by IBM Research and the Institute for Bioengineering and Nanomedicine attack the infected cells while protecting healthy red blood cells.

  • low res

    Polymers

    Date added: 04 Apr 2011

    The polymers, which self-assemble in water, are physically attracted to infected cells and, unlike conventional antiobiotics, enter through the cell membrane (bottom right). Then, the nanostructures destroy infected blood cells from inside, causing the infection to clear (bottom left) without destroying healthy cells.


Contact(s) for the Press kit

Ari Entin
IBM Media Relations
408-927-2272
aentin@us.ibm.com